Search research articles
Contact Us
Filters
Showing results (1-10 of 83) with videos related to
Page
of 9
Sort By:
Journal of Biopharmaceutical Statistics
|
April 10, 2025
Reimagining optimization of clinical trials efficiency through use of statistical innovation, technology and non-standard data sources
Kannan Natarajan, Demissie Alemayehu
The Journal of Biological Chemistry
|
December 8, 2019
Cutting antigenic peptides down to size
Kannan Natarajan, David H Margulies
Scientific Reports
|
July 16, 2025
Enhanced production and structural characterization of exopolysaccharide from Sporocarcina psychrophile MTCC 2908 through two step optimization for therapeutic evaluation
Baidurja Biswas, Subbalaxmi Selvaraj, Kannan Natarajan
Sub-Cellular Biochemistry
|
January 16, 2020
Structure and Function of Molecular Chaperones that Govern Immune Peptide Loading
David H Margulies, Jiansheng Jiang, Kannan Natarajan
Critical Reviews in Biochemistry and Molecular Biology
|
May 16, 2019
Structural aspects of chaperone-mediated peptide loading in the MHC-I antigen presentation pathway
Kannan Natarajan, Jiansheng Jiang, David H Margulies
Current Opinion in Immunology
|
May 14, 2020
Structural and dynamic studies of TAPBPR and Tapasin reveal the mechanism of peptide loading of MHC-I molecules
David H Margulies, Jiansheng Jiang, Kannan Natarajan
Journal of Immunology (Baltimore, Md. : 1950)
|
July 24, 2009
Structural basis of the CD8 alpha beta/MHC class I interaction: focused recognition orients CD8 beta to a T cell proximal position
Rui Wang, Kannan Natarajan, David H Margulies
Advances in Experimental Medicine and Biology
|
October 20, 2019
MHC Molecules, T cell Receptors, Natural Killer Cell Receptors, and Viral Immunoevasins-Key Elements of Adaptive and Innate Immunity
Jiansheng Jiang, Kannan Natarajan, David H Margulies
Iucrj
|
April 24, 2024
Chaperone-mediated MHC-I peptide exchange in antigen presentation
Jiansheng Jiang, Kannan Natarajan, David H Margulies
Clinical Pharmacology and Therapeutics
|
April 1, 2021
Perspectives on Virtual (Remote) Clinical Trials as the "New Normal" to Accelerate Drug Development
Demissie Alemayehu, Robert Hemmings, Kannan Natarajan, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 83) with videos related to
Sort By:
Page
of 9
Journal of Biopharmaceutical Statistics
|
April 10, 2025
Reimagining optimization of clinical trials efficiency through use of statistical innovation, technology and non-standard data sources
Kannan Natarajan, Demissie Alemayehu
The Journal of Biological Chemistry
|
December 8, 2019
Cutting antigenic peptides down to size
Kannan Natarajan, David H Margulies
Scientific Reports
|
July 16, 2025
Enhanced production and structural characterization of exopolysaccharide from Sporocarcina psychrophile MTCC 2908 through two step optimization for therapeutic evaluation
Baidurja Biswas, Subbalaxmi Selvaraj, Kannan Natarajan
Sub-Cellular Biochemistry
|
January 16, 2020
Structure and Function of Molecular Chaperones that Govern Immune Peptide Loading
David H Margulies, Jiansheng Jiang, Kannan Natarajan
Critical Reviews in Biochemistry and Molecular Biology
|
May 16, 2019
Structural aspects of chaperone-mediated peptide loading in the MHC-I antigen presentation pathway
Kannan Natarajan, Jiansheng Jiang, David H Margulies
Current Opinion in Immunology
|
May 14, 2020
Structural and dynamic studies of TAPBPR and Tapasin reveal the mechanism of peptide loading of MHC-I molecules
David H Margulies, Jiansheng Jiang, Kannan Natarajan
Journal of Immunology (Baltimore, Md. : 1950)
|
July 24, 2009
Structural basis of the CD8 alpha beta/MHC class I interaction: focused recognition orients CD8 beta to a T cell proximal position
Rui Wang, Kannan Natarajan, David H Margulies
Advances in Experimental Medicine and Biology
|
October 20, 2019
MHC Molecules, T cell Receptors, Natural Killer Cell Receptors, and Viral Immunoevasins-Key Elements of Adaptive and Innate Immunity
Jiansheng Jiang, Kannan Natarajan, David H Margulies
Iucrj
|
April 24, 2024
Chaperone-mediated MHC-I peptide exchange in antigen presentation
Jiansheng Jiang, Kannan Natarajan, David H Margulies
Clinical Pharmacology and Therapeutics
|
April 1, 2021
Perspectives on Virtual (Remote) Clinical Trials as the "New Normal" to Accelerate Drug Development
Demissie Alemayehu, Robert Hemmings, Kannan Natarajan, et al.
Page
of 9